Full copy can be found at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4111291/
DISCUSSION
LGD-4033 was safe and well tolerated over the range of doses that were evaluated over a 3-week period. Even during this short treatment period, there was clear evidence of the compound’s androgenic...